Isabella II, sometimes called Isabella of Brienne and erroneously Yolanda, was the queen of Jerusalem who reigned from 1212 to 1228. She was the daughter and successor of Maria of Montferrat, who died shortly after giving birth to her. Like her mother, Isabella died young before she could make an impression on politics.
Queen Isabella II of Jerusalem (born 1212)
Queen Isabella II of Jerusalem (born 1212)
On April 25, in the year 1228, Queen Isabella II of Jerusalem (born 1212). This event is recorded as a Notable Deaths event in the history of April 25, one of 419 recorded events on this date across all of history.
1 notable person is associated with this event, including Isabella II of Jerusalem. Learn more below.
Key Facts
- This event took place on April 25, 1228 (AD era).
- It is categorised as a Notable Deaths event in recorded history.
- Referenced in 1 Wikipedia article.
- 1 notable person is recorded as involved in or associated with this event.
- Wikipedia source last updated on 11 April 2026.
On This Date in History 419
This article draws on content from Wikipedia, available under CC BY-SA 4.0.
People Involved
More on April 25
Marla Adams, American television actress (born 1938)
Marla Adams, American television actress (born 1938)
Laurent Cantet, French director, cinematographer and screenwriter (born 1961)
Laurent Cantet, French director, cinematographer and screenwriter (born 1961)
Harry Belafonte, American singer, activist, and actor (born 1927)
Harry Belafonte, American singer, activist, and actor (born 1927)
John Havlicek, American basketball player (born 1940)
John Havlicek, American basketball player (born 1940)
Madeeha Gauhar, Pakistani actress, playwright and director of social theater, and women's rights activist (born 1956)
Madeeha Gauhar, Pakistani actress, playwright and director of social theater, and women's rights activist (born 1956)
Tom Lewis, Australian politician, 33rd Premier of New South Wales (born 1922)
Tom Lewis, Australian politician, 33rd Premier of New South Wales (born 1922)
Comments 0
Sign in to join the discussion.